Vaccine-preventable Viruses Associated with Increased Risk for Neurodegenerative Disease: NIH Findings
The large biobank-based study found 22 pairings of a neurodegenerative disorder and a previous viral infection. Vaccines exist against several of those viruses.
Menopausal Hormone Therapy Appropriate for Women at Low ASCVD Risk, According to Review
A new review found that menopausal hormone therapy for vasomotor symptoms is safe and appropriate for most women at low atherosclerotic cardiovascular disease risk.
AAFP: National Plan Needed to Transition Out of COVID Public Health Emergency
The AAFP wants assurances in policies to avoid disruptions for doctors and patients even though HHS says it plans to preserve some flexibilities.
Zavegepant Intranasal Migraine Agent Meets Coprimary Endpoints in Phase 3 Trial, Pfizer Announces
Pain relief from the intranasally-delivered calcitonin gene-related peptide antagonist began as soon as 15 minutes post-dose and for some patients lasted up to 48 hours.
Daily Dose: COPD Diagnosis in Primary Care
Your daily dose of clinical news you may have missed.
Combination Pharmacotherapy for Neuropathic Pain: Is it Better than Monotherapy?
Is combination pharmacotherapy better for neuropathic pain than monotherapy? A recent systematic review and meta-analysis has answers.
Risk of Stroke May Diminish with Age in Persons with Diabetes and Hypertension: New Findings
The magnitude of the association with age did not change, however, for other stroke risk factors, including smoking, atrial fibrillation, and LVH, investigators report.
Cedars-Sinai Study Said to Confirm Increased Risk of New-onset T2D After COVID-19 Infection
The EHR analysis found greater risk of type 2 diabetes after COVID regardless of vaccination status although odds were greater for those unvaccinated before infection.
Daily Dose: Trends in Obesity Prevalence in Adults with Diabetes
Irregular Sleeping Habits Associated with Measures of Subclinical Atherosclerosis in New Study
Sleep duration irregularity was associated with measures of subclinical atherosclerosis in a racially and ethnically diverse study of more than 2000 adults.
Simple 5-question Screening Tool Could Improve COPD Diagnosis in Primary Care
The CAPTURE tool was able to identify 50% of primary care patients with COPD who could immediately benefit from treatment; experts say, it's a start.
Use of Primary Care Visits for Mental Health Concerns Rising Steadily, Study Finds
Primary care is increasingly the setting for mental health discussions, diagnosis, and treatment, underscoring the need for both structural and process change.
Best Practices in the Utilization of Preventative Testing and Screening to Optimize Men’s Health
Experts in the management of men’s health provide their input on the best practices in preventative testing and screening measures to optimize the health of male patients.
It's Still Flu Season, Don't Let Patients Drop Their Guard, Says Expert
Medical director of the NFID William Schaffner, MD, shares his messages to primary care clinicians as the final months of this year's flu season near.
Daily Dose: Predicting Severe COPD Exacerbations with CT Biomarkers
Large-for-Gestational-Age Births Increase Long-term Risk for Diabetes: Study
Women who gave birth to infants in the highest birthweight category were at a 21% increased risk for prediabetes/diabetes 10 to 14 years later.
Prevalence of Obesity Increasing Among US Adults with Diabetes, According to NHANES Analysis
The proportion of adults with diabetes and obesity in the US increased from 1999 to 2020, though more adults achieved blood pressure and lipid control during the same period.
CPAP Compliance Improves Lung Function in Patients with Comorbid OSA and COPD
Among patients with COPD and OSA, those with consistent CPAP compliance over 12 months showed improved lung function and experienced fewer AECOPD.
Changes to the ACIP 2023 Adult Immunization Schedule
Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≥19 years in the US.
Changes to the ACIP 2023 Child & Adolescent Immunization Schedule
Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≤18 years in the US.